General Information
Revision date
2026-09-07
Product name
GENETICIN
CAS No.
108321-42-2
1.2.1 Relevant identified uses
For research use only. Not for use in diagnostic procedures
1.2.2. Uses advised against
Consumer use
supplier name
Life Technologies Europe BV
Manufacturer Name
Life Technologies Europe BV
Emergency telephone
1-800-424-9300, 1-703-527-3887, 1-703-741-5970, +(43)-13649237, +(32)-28083237, +(45)-69918573, +(358)-942419014, +(33)-975181407, +(49)- 69643508409, +(353)-19014670, 800-789-767, +(39)-0245557031, +39 06-68593726, +39 06-49978000, +39 06-3054343, +39 02-66101029, +39 081-5453333, +39 055-7947819, +39 800883300, +39 800183459, +39 0382-24444, +39 800011858, +41 44 251 51 51, +(31)-858880596, +(47)-21930678, +48 22 398 80 29, +(351)-308801773, +(34)-931768545, +(46)-852503403, +(41)-435082011, +(44)-870-...
Icons in SDS
Company Information
company name
Life Technologies Europe BV
e-mail address of the competent person responsible for the Safety Data Sheet
MSDS@lifetech.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H334
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Classification according to Regulation (EC) No. 1272/2008 [CLP Classification of the substance or mixture
Contains
G418 sulfate CAS No. 108321-42-2
Signal word
Danger
Hazard statements
H317 - May cause an allergic skin reaction. H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Precautionary statements
P261 - Avoid breathing dust, fume, gas, mist, vapors and spray. P280 - Wear protective gloves. P304 + P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. P342 + P311 - If experiencing respiratory symptoms: Call a POISON CENTER or doctor. P501 - Dispose of contents and container in accordance with local, regional, national, and international regulations as applicable. P321 - Specific treatment (see supplemental first aid instructions on this label).
Additional information
This product requires tactile warnings if supplied to the general public.
Other hazards
No information available. PBT or vPvB properties This substance does not meet the PBT/vPvB criteria of REACH, Annex XIII. Endocrine Disruptor Information The substance is identified as having no endocrine disrupting properties according to
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Respiratory sensitisation Category 1 - (H334) Skin sensitisation Category 1 - (H317)
